Wednesday 14th - Monday 19th June 2017
Real-world evidence can enhance clinical decision-making
Real-world data generated using rigorous scientific methods can complement randomised controlled trials by providing unique insights for practicing evidence-based medicine, delegates attending this year’s EULAR congress in Madrid have been told. Speaking during an AbbVie sponsored symposium tit...Sponsored by AbbVie Pty Ltd.
Certolizumab doesn’t cross the placenta
The continuation of the anti-TNF certolizumab during pregnancy may be an option for women who need their disease activity controlled because it doesn’t cross the placenta in significant concentrations, a pharmacokinetic study shows. Presenting their findings at EULAR the authors led by Professo...
Full blown RA prevented with early treatment
Early therapeutic intervention significantly reduces the risk of RA onset in pre-RA patients, a meta analysis presented at the EULAR congress in Madrid shows. The meta-analysis of studies set out to examine the effectiveness of steroids, csDMARDs and bDMARDS on preventing RA and structural damage...